XT
VBIO

XTX Topco’s Valion Bio VBIO Stock Holding History

XTX Topco’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.31K Buy
+10,506
New +$10.8K ﹤0.01% 3700

Other funds holding VBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

XTX Topco's VBIO Position: Q1 2026 in Review

XTX Topco opened a new position in Valion Bio (VBIO) in Q1 2026: 10,506 shares worth $9.31K. The stake represents ﹤0.01% of the portfolio and ranks #3700 among its holdings.

9 funds tracked by Wall St. Rank hold VBIO as of Q1 2026.

  • XTX Topco held 10,506 shares of Valion Bio worth $9.31K as of Q1 2026.
  • Valion Bio was a new XTX Topco position in Q1 2026.
  • Valion Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3700 holding.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.